Plain-English translation of NCT05797077 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether patients with colorectal cancer that has spread to the liver benefit from receiving maintenance therapy in addition to standard chemotherapy after surgery. The study focuses on patients whose blood shows signs of remaining cancer cells after their surgery (detected through a blood test). Researchers want to know if this combination approach helps people stay cancer-free longer than chemotherapy alone.
After surgery to remove liver tumors, some patients have signs of cancer cells remaining in their blood, which puts them at higher risk of cancer returning. This trial exists to find out whether adding maintenance therapy to the standard chemotherapy can help prevent that recurrence and improve long-term outcomes.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive either chemotherapy alone or chemotherapy combined with maintenance therapy after your surgery. The study will track how long you stay cancer-free and monitor your health through regular visits and blood tests. Your participation will help doctors understand which treatment approach works best for patients like you.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
China